T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Inogen
INGN
$154M
| $2.69M | ﹤0.01% |
85,606
+20,497
| +31% | +$497K |
|
1527
ResMed
RMD
$32.8B
| $2.65M | ﹤0.01% |
47,356
-1,560
| -3% | -$81.5K |
|
1528
Lands' End
LE
$391M
| $2.63M | ﹤0.01% |
48,690
+37,200
| +324% | +$1.75M |
|
1529
Annaly Capital Management
NLY
$17.4B
| $2.62M | ﹤0.01% |
60,678
-10,051
| -14% | -$454K |
|
1530
Kratos Defense & Security Solutions
KTOS
$11.8B
| $2.62M | ﹤0.01% |
522,391
-4,401,751
| -89% | -$24.9M |
|
1531
TTEC Holdings
TTEC
$77.4M
| $2.62M | ﹤0.01% |
110,590
-2,500
| -2% | -$59.9K |
|
1532
Crawford & Co Class B
CRD.B
$576M
| $2.6M | ﹤0.01% |
252,428
-1,300
| -0.5% | -$12.2K |
|
|
UNT
1533
DELISTED
UNIT Corporation
UNT
| $2.58M | ﹤0.01% |
75,800
+200
| +0.3% | +$8.65K |
|
1534
HNI Corp
HNI
$3.55B
| $2.58M | ﹤0.01% |
50,580
-2,000
| -4% | -$90.2K |
|
|
TVRD
1535
Tvardi Therapeutics
TVRD
$22.1M
| $2.53M | ﹤0.01% |
7,045
-7
| -0.1% | -$2.25K |
|
|
JAH
1536
DELISTED
JARDEN CORPORATION
JAH
| $2.52M | ﹤0.01% |
52,623
-5,250
| -9% | -$228K |
|
1537
AGNC Investment
AGNC
$13B
| $2.46M | ﹤0.01% |
112,850
-15,017
| -12% | -$339K |
|
|
SALE
1538
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $2.45M | ﹤0.01% |
167,855
+370
| +0.2% | +$5.78K |
|
1539
Arch Capital
ACGL
$33.2B
| $2.43M | ﹤0.01% |
123,504
+39,375
| +47% | +$747K |
|
1540
Rio Tinto
RIO
$160B
| $2.4M | ﹤0.01% |
52,132
+5,242
| +11% | +$247K |
|
1541
Mid-America Apartment Communities
MAA
$15.4B
| $2.32M | ﹤0.01% |
31,032
| – | – |
|
|
VER
1542
DELISTED
VEREIT, Inc.
VER
| $2.3M | ﹤0.01% |
50,887
| – | – |
|
|
OCR
1543
DELISTED
OMNICARE INC
OCR
| $2.29M | ﹤0.01% |
31,409
-4,530
| -13% | -$307K |
|
1544
Qualys
QLYS
$6.47B
| $2.28M | ﹤0.01% |
60,427
-122,406
| -67% | -$4.08M |
|
1545
SLM Corp
SLM
$5.26B
| $2.27M | ﹤0.01% |
222,798
-2,435,985
| -92% | -$23.3M |
|
1546
Everest Group
EG
$13.9B
| $2.25M | ﹤0.01% |
13,230
-139
| -1% | -$23.5K |
|
1547
Extra Space Storage
EXR
$31B
| $2.25M | ﹤0.01% |
38,300
-1,300
| -3% | -$74.5K |
|
1548
Liberty Media Series A
FWONA
$23.7B
| $2.23M | ﹤0.01% |
94,176
-33,978
| -27% | -$802K |
|
1549
Canadian National Railway
CNI
$76.4B
| $2.23M | ﹤0.01% |
32,220
+1,400
| +5% | +$95.8K |
|
1550
Arthur J. Gallagher & Co
AJG
$65.5B
| $2.21M | ﹤0.01% |
46,960
+3,700
| +9% | +$174K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.